Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.0047 | 0.0353 | 0.5 | |
Plasmodium falciparum | cysteine proteinase falcipain 2b | 0.0047 | 0.0353 | 0.5 |
Echinococcus multilocularis | cathepsin l cysteine peptidase | 0.0047 | 0.0353 | 0.0424 |
Trypanosoma cruzi | DNA polymerase beta thumb, putative | 0.0049 | 0.0394 | 0.0043 |
Toxoplasma gondii | hypothetical protein | 0.0056 | 0.0625 | 1 |
Plasmodium vivax | vivapain-2 | 0.0047 | 0.0353 | 0.5 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0049 | 0.0394 | 0.0043 |
Plasmodium falciparum | cysteine proteinase falcipain 2a | 0.0047 | 0.0353 | 0.5 |
Giardia lamblia | Cathepsin B precursor | 0.0052 | 0.0503 | 0.5 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0052 | 0.0503 | 0.0495 |
Echinococcus multilocularis | cathepsin L cysteine protease | 0.0047 | 0.0353 | 0.0424 |
Echinococcus multilocularis | cathepsin b | 0.0142 | 0.3391 | 0.4071 |
Leishmania major | cathepsin L-like protease | 0.0047 | 0.0353 | 0.0353 |
Leishmania major | cathepsin L-like protease | 0.0047 | 0.0353 | 0.0353 |
Leishmania major | cysteine peptidase A (CPA) | 0.0047 | 0.0353 | 0.0353 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0183 | 0.471 | 0.5 |
Trypanosoma cruzi | DNA polymerase beta thumb, putative | 0.0049 | 0.0394 | 0.0043 |
Echinococcus granulosus | tachykinin peptides receptor 99D | 0.0295 | 0.833 | 1 |
Schistosoma mansoni | SmCB2 peptidase (C01 family) | 0.0142 | 0.3391 | 1 |
Echinococcus multilocularis | cysteine protease | 0.0047 | 0.0353 | 0.0424 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0347 | 1 | 1 |
Echinococcus granulosus | cathepsin L cysteine proteinase | 0.0047 | 0.0353 | 0.0424 |
Trypanosoma brucei | DNA polymerase beta thumb, putative | 0.0049 | 0.0394 | 0.0043 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0052 | 0.0503 | 1 |
Echinococcus granulosus | cathepsin l cysteine peptidase | 0.0047 | 0.0353 | 0.0424 |
Onchocerca volvulus | 0.0047 | 0.0353 | 0.5 | |
Onchocerca volvulus | 0.0047 | 0.0353 | 0.5 | |
Echinococcus multilocularis | cysteine protease | 0.0047 | 0.0353 | 0.0424 |
Giardia lamblia | Cathepsin B precursor | 0.0052 | 0.0503 | 0.5 |
Plasmodium falciparum | cysteine proteinase falcipain 3 | 0.0047 | 0.0353 | 0.5 |
Echinococcus granulosus | cathepsin l1 | 0.0047 | 0.0353 | 0.0424 |
Echinococcus multilocularis | cathepsin b | 0.0142 | 0.3391 | 0.4071 |
Echinococcus granulosus | cathepsin b | 0.0142 | 0.3391 | 0.4071 |
Trypanosoma brucei | cysteine peptidase C (CPC) | 0.0052 | 0.0503 | 0.0156 |
Leishmania major | cathepsin L-like protease | 0.0047 | 0.0353 | 0.0353 |
Onchocerca volvulus | 0.0047 | 0.0353 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0142 | 0.3391 | 1 |
Leishmania major | mitochondrial DNA polymerase beta-PAK, putative | 0.0164 | 0.4112 | 0.4112 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0347 | 1 | 1 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0052 | 0.0503 | 0.0156 |
Plasmodium vivax | vivapain-2 | 0.0047 | 0.0353 | 0.5 |
Loa Loa (eye worm) | cathepsin B | 0.0052 | 0.0503 | 0.0495 |
Entamoeba histolytica | cysteine proteinase, putative | 0.0047 | 0.0353 | 0.5 |
Brugia malayi | cathepsin B-like cysteine proteinase | 0.0142 | 0.3391 | 1 |
Leishmania major | cathepsin L-like protease | 0.0047 | 0.0353 | 0.0353 |
Leishmania major | cathepsin L-like protease | 0.0047 | 0.0353 | 0.0353 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0142 | 0.3391 | 1 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0164 | 0.4112 | 0.3897 |
Onchocerca volvulus | 0.0047 | 0.0353 | 0.5 | |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0142 | 0.3391 | 1 |
Leishmania major | cathepsin L-like protease | 0.0047 | 0.0353 | 0.0353 |
Entamoeba histolytica | cysteine protease, putative | 0.0047 | 0.0353 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0183 | 0.471 | 0.5 |
Echinococcus granulosus | cathepsin b | 0.0142 | 0.3391 | 0.4071 |
Onchocerca volvulus | Cathepsin L homolog | 0.0047 | 0.0353 | 0.5 |
Onchocerca volvulus | 0.0047 | 0.0353 | 0.5 | |
Onchocerca volvulus | Cathepsin F homolog | 0.0047 | 0.0353 | 0.5 |
Onchocerca volvulus | 0.0047 | 0.0353 | 0.5 | |
Entamoeba histolytica | cysteine proteinase, putative | 0.0047 | 0.0353 | 0.5 |
Echinococcus multilocularis | cathepsin l cysteine peptidase | 0.0047 | 0.0353 | 0.0424 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0142 | 0.3391 | 1 |
Onchocerca volvulus | Cathepsin L homolog | 0.0047 | 0.0353 | 0.5 |
Echinococcus multilocularis | cathepsin L cysteine protease | 0.0047 | 0.0353 | 0.0424 |
Leishmania major | cathepsin L-like protease | 0.0047 | 0.0353 | 0.0353 |
Echinococcus multilocularis | tachykinin peptides receptor 99D | 0.0295 | 0.833 | 1 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0142 | 0.3391 | 0.3149 |
Leishmania major | cysteine peptidase C (CPC),CPC cysteine peptidase, Clan CA, family C1, Cathepsin B-like | 0.0052 | 0.0503 | 0.0503 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0059 | 0.0738 | 0.0399 |
Toxoplasma gondii | cathepsin B | 0.0052 | 0.0503 | 0.5522 |
Leishmania major | cathepsin L-like protease | 0.0047 | 0.0353 | 0.0353 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0164 | 0.4112 | 0.3897 |
Giardia lamblia | Cathepsin B precursor | 0.0052 | 0.0503 | 0.5 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0347 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | = 2.4 uM | Cytotoxicity against human COLO205 cells after 48 hrs by sulforhodamine B based ELISA | ChEMBL. | 21402478 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.